94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Inna Gertsenshteyn1,2,3†Boris Epel1,3,4†Mihai Giurcanu5Eugene Barth1,3John Lukens1,3Kayla Hall1,3Jenipher Flores Martinez1,3Mellissa Grana1,3Matthew Maggio1,3Richard C. Miller1,3Subramanian V. Sundramoorthy1,3Martyna Krzykawska-Serda3,6Erik Pearson1,3Bulent Aydogan1Ralph R. Weichselbaum1Victor M. Tormyshev7Mrignayani Kotecha4
Howard J. Halpern1,3*- 1Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, United States
- 2Department of Radiology, The University of Chicago, Chicago, IL, United States
- 3Center for EPR Imaging in vivo Physiology, The University of Chicago, Chicago, IL, United States
- 4O2M Technologies, Chicago, IL, United States
- 5Department of Public Health Sciences, The University of Chicago, Chicago, IL, United States
- 6Department of Biophysics and Cancer Biology, Jagiellonian University, Kraków, Poland
- 7Novosibirsk Institute of Organic Chemistry, Novosibirsk, Russia
A corrigendum on
Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models
by Gertsenshteyn I, Epel B, Giurcanu M, Barth E, Lukens J, Hall K, Martinez JF, Grana M, Maggio M, Miller RC, Sundramoorthy SV, Krzykawska-Serda M, Pearson E, Aydogan B, Weichselbaum RR, Tormyshev VM, Kotecha M and Halpern HJ (2023). Front. Med. 10:1269689. doi: 10.3389/fmed.2023.1269689
In the published article, there was an error in the Funding statement. The National Institutes of Health grant R01 CA236385 was missing in the statement. The correct funding statement appears below.
Funding
“The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Funding sources provided by the National Institutes of Health grants P41 EB002034, R01 CA098575, R01 CA236385, R50 CA211408, P30 CA014599, T32 EB002103, R44 CA224840 (SBIR Phase II to O2M, PI: Kotecha), and F31 CA254223.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hypoxia, oxygen, electron paramagnetic resonance, preclinical imaging, radiotherapy
Citation: Gertsenshteyn I, Epel B, Giurcanu M, Barth E, Lukens J, Hall K, Martinez JF, Grana M, Maggio M, Miller RC, Sundramoorthy SV, Krzykawska-Serda M, Pearson E, Aydogan B, Weichselbaum RR, Tormyshev VM, Kotecha M and Halpern HJ (2023) Corrigendum: Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models. Front. Med. 10:1339872. doi: 10.3389/fmed.2023.1339872
Received: 16 November 2023; Accepted: 21 November 2023;
Published: 05 December 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Gertsenshteyn, Epel, Giurcanu, Barth, Lukens, Hall, Martinez, Grana, Maggio, Miller, Sundramoorthy, Krzykawska-Serda, Pearson, Aydogan, Weichselbaum, Tormyshev, Kotecha and Halpern. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Howard J. Halpern, aGhhbHBlcm5AdWNoaWNhZ28uZWR1
†These authors have contributed equally to this work and share first authorship